Israel Englander’s RAPT Therapeutics RAPT Stock Holding History

Israel Englander’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,375	Closed	-$2.08M	–	7279
2021 Q3	$2.08M	Buy	+8,375	New	+$2.21M	﹤0.01%	3856
2021 Q2	–	Sell	-2,163	Closed	-$384K	–	7000
2021 Q1	$384K	Buy	+2,163	New	+$357K	﹤0.01%	5038

Israel Englander's RAPT Position: Q1 2026 in Review

Israel Englander sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 106,671 shares — an estimated $3.61M sold.

Israel Englander first reported a position in RAPT in Q1 2020 and held it in 24 quarters. The position peaked at $15.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Israel Englander reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Israel Englander sold 106,671 RAPT Therapeutics shares in Q1 2026, an estimated $3.61M.
Israel Englander first reported a position in RAPT Therapeutics in Q1 2020 and held it in 24 quarters.
Israel Englander's RAPT Therapeutics position peaked at $15.4M in Q3 2021.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.